Gufic Biosciences Ltd. | Small-cap | Healthcare
₹349.15
-0.71%
| Gufic Biosciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 8.2B
Gross Profit 4.5B 54.29%
Operating Income 1.1B 13.86%
Net Income 696.5M 8.50%

Balance Sheet Metrics

Total Assets 11.7B
Total Liabilities 5.7B
Shareholders Equity 6.0B
Debt to Equity 0.95

Cash Flow Metrics

Operating Cash Flow 833.6M
Free Cash Flow 470.4M

Revenue & Profitability Trend

Gufic Biosciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 8.2B 7.7B 6.8B 7.1B 4.9B
Cost of Goods Sold 3.7B 4.0B 3.4B 4.2B 2.6B
Gross Profit 4.5B 3.7B 3.4B 2.9B 2.3B
Operating Expenses 1.8B 1.4B 1.2B 1.1B 741.6M
Operating Income 1.1B 1.3B 1.2B 1.3B 681.5M
Pre-tax Income 941.4M 1.2B 1.1B 1.3B 577.1M
Income Tax 244.9M 295.4M 270.2M 310.0M 134.8M
Net Income 696.5M 861.4M 797.0M 958.4M 442.3M
EPS (Diluted) - ₹8.74 ₹8.22 ₹9.89 ₹4.56

Income Statement Trend

Gufic Biosciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 6.2B 6.0B 4.6B 3.2B 2.6B
Non-Current Assets 5.4B 4.9B 4.0B 2.0B 1.3B
Total Assets 11.7B 10.9B 8.6B 5.2B 3.9B
Liabilities
Current Liabilities 3.9B 3.7B 2.9B 1.9B 1.6B
Non-Current Liabilities 1.8B 1.9B 2.3B 658.8M 549.6M
Total Liabilities 5.7B 5.6B 5.1B 2.5B 2.2B
Equity
Total Shareholders Equity 6.0B 5.3B 3.5B 2.7B 1.7B

Balance Sheet Composition

Gufic Biosciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 696.5M 861.4M 797.0M 958.4M 442.3M
Operating Cash Flow 833.6M -693.0M -361.1M 558.0M 677.4M
Investing Activities
Capital Expenditures -707.6M -1.1B -1.9B -873.8M -124.0M
Investing Cash Flow -717.1M -1.0B -1.9B -951.6M -72.5M
Financing Activities
Dividends Paid -10.0M -9.7M -10.4M -9.2M -3.6M
Financing Cash Flow -245.5M 1.0B 2.5B -13.3M -1.3B
Free Cash Flow 470.4M -1.2B -2.1B 187.9M 748.5M

Cash Flow Trend

Gufic Biosciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 49.90
Price to Book 5.78
Price to Sales 4.24

Profitability Ratios

Profit Margin 8.50%
Operating Margin 9.04%
Return on Equity 12.29%
Return on Assets 6.28%

Financial Health

Current Ratio 1.61
Debt to Equity 55.93
Beta 0.33

Per Share Data

EPS (TTM) ₹6.94
Book Value per Share ₹59.96
Revenue per Share ₹81.81

Financial data is updated regularly. All figures are in the company's reporting currency.